A clinically governed workflow platform that connects UK dementia specialists with local clinicians and caregivers — enabling faster diagnosis, safer medication titration, and continuous monitoring across distributed care settings.
Dementia pathways suffer from delays at every stage — fragmented referrals, unsafe titration gaps, and impossible-to-trace clinical decisions across borders.
Materials arrive via fax, scan, and email — incomplete, inconsistent, and buried in scanned paperwork. Specialists waste time chasing basic information before they can even begin a review.
Safe dose changes require repeated data capture and timely review. In practice, information comes back late, in inconsistent formats, or without enough context for confident dose decisions.
When specialists provide clinical plans across jurisdictions, local clinicians need a clear and legally bounded role. Without a system of record, accountability becomes dangerously blurred.
Difficult to demonstrate who decided what, when they decided it, and on which evidence base. This creates medico-legal risk and governance gaps across the care pathway.
The platform turns specialist intent into an executable care pathway — without replacing clinical judgement.
This is not a replacement for specialist clinical judgement, nor an autonomous diagnostic or prescribing system.
UK specialists hold diagnostic and treatment authority. Local clinicians execute and contribute structured data. Caregivers provide observations between formal reviews.
From initial referral through to long-term monitoring, every step is structured, tracked, and auditable.
Referral material ingested from fax, upload, or email. System extracts key fields, flags uncertainty, and presents a normalised summary to the specialist.
UK specialist reviews the case, records diagnosis, and establishes the initial treatment protocol. Dose logic is checked against configured safety rules.
Specialist sets the titration schedule. Local clinicians and caregivers receive prompts to submit weight, symptoms, and side effect observations.
Scheduled monitoring period. Specialist reviews observations, maintains or modifies the treatment plan. All decisions remain on the clinical timeline.
Intake, decision support, titration, monitoring — unified in a single clinically governed platform.
Convert faxed or scanned clinical material into structured data fields.
History, protocol, timeline, and source artefacts in one place.
Define diagnosis, medication, starting dose, frequency, and titration plan.
Configurable rules with weight-based thresholds and out-of-range alerts.
Prompt caregivers and clinicians for required submissions at the right time.
Capture weight, behaviour, side effects, and context in a consistent format.
Record decisions, rationale, timing, and actor identity in a defensible timeline.
Generate case summaries for local records, governance, or onward communication.
Decision support highlights missing data and unsafe ranges but never generates autonomous clinical recommendations — a critical distinction under UK healthcare law.
The platform is designed to align with NHS information governance expectations and UK medico-legal standards. Decision support highlights risks but preserves the specialist as the sole clinical decision-maker — a distinction that matters operationally and legally.
Every action traceable. Every decision defensible. Every data flow justified.
Role-based permissions encoded into the platform. Every action traceable to a named user with documented access policies.
Designed around NHS information governance expectations with strong security controls and documented access policies.
Explicit consent records, residency logic, and defensible rationale for international data flows across the UK, US, and Caribbean.
Every clinical decision preserves legal context — UK specialist decisions executed locally are fully traceable to user, time, and evidence set.
The MVP privileges workflow reliability over feature breadth. The test: can the specialist safely run real cases with less friction than today?
"The right question is not how many features can be launched, but whether the specialist can confidently run real cases through the platform with less friction than today."
Five outcome measures designed to validate the operational model before scaling.
The Teledementia platform addresses both a service need and a system need — timely dementia care delivered through a governed mechanism for cross-border specialist coordination.